Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial

BACKGROUND: Genital infection with herpes simplex virus type 2 (HSV-2) is common and increases risk of human immunodeficiency virus (HIV) transmission and acquisition. Pericoital use of tenofovir (TFV) gel provided protection from HSV-2 acquisition in the CAPRISA 004 study. METHODS: We measured esti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Marrazzo, Jeanne M, Rabe, Lorna, Kelly, Cliff, Richardson, Barbra, Deal, Carolyn, Schwartz, Jill L, Chirenje, Z M, Piper, Jeanna, Morrow, Rhoda Ashley, Hendrix, Craig W, Marzinke, Mark A, Hillier, Sharon L
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534189/
https://ncbi.nlm.nih.gov/pubmed/30753642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz045
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados